PAC326-A Randomized Controlled Phase 3 Study of Oral Pacritinib versus Best Available Therapy in Patients with Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytopenia Myelofibrosis

  • Jana, Bagi (PI)

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date3/2/15 → 3/1/17

    Funding

    • CTI BioPHarma: $6,300.00